{
    "id": "dbpedia_36_1",
    "rank": 78,
    "data": {
        "url": "https://www.researchgate.net/scientific-contributions/Romain-Dalmann-2059730821",
        "read_more_link": "",
        "language": "en",
        "title": "Université Clermont Auvergne and other places",
        "top_image": "https://www.researchgate.net/_next-assets/images/favicon.ico",
        "meta_img": "https://www.researchgate.net/_next-assets/images/favicon.ico",
        "images": [
            "https://www.researchgate.net/publication/337313680/figure/fig1/AS:11431281250175265@1717769436544/Effects-of-paracetamol-on-brain-functional-connectivity-during-both-rest-and-acute-pain_Q320.jpg",
            "https://www.researchgate.net/publication/337313680/figure/fig2/AS:11431281250136775@1717769447738/Effects-of-paracetamol-on-periaqueductal-grey-functioning-a-Brain-slices-showing-fALFF_Q320.jpg",
            "https://www.researchgate.net/publication/337313680/figure/fig3/AS:11431281250091075@1717769454404/In-the-periaqueductal-grey-PAG-paracetamol-metabolites-p-aminophenol-and-AM404-induce_Q320.jpg",
            "https://www.researchgate.net/publication/337313680/figure/fig4/AS:11431281250109253@1717769461007/Involvement-of-TRPV1-channels-in-PAG-during-challenge-with-paracetamol-a_Q320.jpg",
            "https://www.researchgate.net/publication/337313680/figure/fig5/AS:11431281250099475@1717769470479/FAAH-dependent-changing-of-glutamate-and-GABA-stores-during-paracetamol-challenge-a_Q320.jpg",
            "https://i1.rgstatic.net/partner-brand/asset/AS:11431281249763182@1717600491364/logo",
            "https://i1.rgstatic.net/ii/profile.image/985229644800006-1611908460488_Q64/David-Barriere.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://www.researchgate.net/profile/Youssef-Aissouni/publication/287212105/figure/fig1/AS:320625584427008@1453454504297/A-Time-course-of-static-mechanical-allodynia-in-the-electronic-von-Frey-test-Data-are_Q320.jpg",
            "https://www.researchgate.net/profile/Youssef-Aissouni/publication/287212105/figure/fig6/AS:668645009133576@1536428801309/Relative-quantity-RQ-scatter-plots-of-the-6-transcripts-differentially-expressed-in-the_Q320.jpg",
            "https://www.researchgate.net/profile/Youssef-Aissouni/publication/287212105/figure/fig2/AS:320625584427009@1453454504332/Representative-Western-blot-of-the-expression-of-M2-receptor-proteins-in-the-left-pIC-of_Q320.jpg",
            "https://www.researchgate.net/profile/Youssef-Aissouni/publication/287212105/figure/fig3/AS:320625584427010@1453454504355/Effect-of-M2-receptor-activation-in-the-posterior-insular-cortex-on-neuropathic-pain-A_Q320.jpg",
            "https://www.researchgate.net/profile/Youssef-Aissouni/publication/287212105/figure/fig4/AS:320625584427011@1453454504389/Pharmacological-evaluation-of-oral-donepezil-on-oxaliplatin-induced-neuropathy-A_Q320.jpg",
            "https://i1.rgstatic.net/ii/profile.image/612078855413760-1522942379115_Q64/Jeremy-Ferrier.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://i1.rgstatic.net/ii/profile.image/728739126202369-1550756355355_Q64/David-Balayssac.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://i1.rgstatic.net/partner-brand/asset/AS:11431281249763182@1717600491364/logo",
            "https://i1.rgstatic.net/ii/profile.image/985229644800006-1611908460488_Q64/David-Barriere.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://i1.rgstatic.net/ii/profile.image/612078855413760-1522942379115_Q64/Jeremy-Ferrier.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://i1.rgstatic.net/ii/profile.image/728739126202369-1550756355355_Q64/David-Balayssac.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://i1.rgstatic.net/ii/profile.image/612078855413760-1522942379115_Q64/Jeremy-Ferrier.jpg",
            "https://i1.rgstatic.net/ii/profile.image/985229644800006-1611908460488_Q64/David-Barriere.jpg",
            "https://i1.rgstatic.net/ii/profile.image/337022884564995-1457363925411_Q64/Fabien-Marchand.jpg",
            "https://i1.rgstatic.net/ii/profile.image/728739126202369-1550756355355_Q64/David-Balayssac.jpg",
            "https://i1.rgstatic.net/ii/profile.image/294909480325121-1447323307079_Q64/Matthieu-Keller.jpg",
            "https://c5.rgstatic.net/m/4671872220764/images/template/default/profile/profile_default_m.jpg",
            "https://i1.rgstatic.net/cdn-cgi/image/width=48,format=auto/ii/institution.image/AS%3A563551719116800%401511372608514_m 1x, https://i1.rgstatic.net/cdn-cgi/image/width=96,format=auto/ii/institution.image/AS%3A563551719116800%401511372608514_m 2x",
            "https://www.researchgate.net/_next-assets/images/mobileapp/app_store_dark_logo.svg",
            "https://www.researchgate.net/_next-assets/images/mobileapp/playstore.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Romain Dalmann's 5 research works with 88 citations, including: Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey",
        "meta_lang": "en",
        "meta_favicon": "/_next-assets/images/favicon.ico",
        "meta_site_name": "ResearchGate",
        "canonical_link": "https://www.researchgate.net/scientific-contributions/Romain-Dalmann-2059730821",
        "text": "Background and Purpose We previously demonstrated that paracetamol has to be metabolised in the brain by fatty acid amide hydrolase enzyme into AM404 (N‐(4‐hydroxyphenyl)‐5Z,8Z,11Z,14Z‐eicosatetraenamide) to activate CB1 receptors and TRPV1 channels, which mediate its analgesic effect. However, the brain mechanisms supporting paracetamol‐induced analgesia remain unknown. Experimental Approach The effects of paracetamol on brain function in Sprague‐Dawley rats were determined by functional MRI. Levels of neurotransmitters in the periaqueductal grey (PAG) were measured using in vivo ¹H‐NMR and microdialysis. Analgesic effects of paracetamol were assessed by behavioural tests and challenged with different inhibitors, administered systemically or microinjected in the PAG. Key Results Paracetamol decreased the connectivity of major brain structures involved in pain processing (insula, somatosensory cortex, amygdala, hypothalamus, and the PAG). This effect was particularly prominent in the PAG, where paracetamol, after conversion to AM404, (a) modulated neuronal activity and functional connectivity, (b) promoted GABA and glutamate release, and (c) activated a TRPV1 channel‐mGlu5 receptor‐PLC‐DAGL‐CB1 receptor signalling cascade to exert its analgesic effects. Conclusions and Implications The elucidation of the mechanism of action of paracetamol as an analgesic paves the way for pharmacological innovations to improve the pharmacopoeia of analgesic agents.\n\nLe paracétamol est sujet à controverse depuis sa découverte. Que ce soit son mécanisme d’action, ses effets indésirables ou son efficacité, de nombreuses études ont été réalisées et parfois se contredisent. Parfois critiqué pour son efficacité limitée, il n’a pourtant rien à envier aux autres antalgiques : il soulage les douleurs faibles à modérées sans effets indésirables aux doses thérapeutiques. Cela en fait un médicament de premier recours chez la femme enceinte, le nourrisson et l’enfant. D’après un rapport de l’ANSM, sur les 30 substances actives les plus vendues en France en 2013 (montant total 1,15 milliard de boîtes), le paracétamol domine très largement (plus de 500 millions de boîtes). C'est l’antalgique et l’antipyrétique le plus consommé au monde. La pharmacopée des antalgiques est vieillissante, l’évolution de l’arsenal thérapeutique depuis 50 ans est limitée. Ce constat amène à réévaluer les stratégies de recherche. Maintenant, notre intérêt serait de comprendre les mécanismes et les cibles de ces antalgiques afin de développer des analogues plus affins tout en limitant leurs effets indésirables. Basée cette stratégie, le paracétamol est un parfait candidat. En effet, son mécanisme d’action n’est pas parfaitement connu mais son efficacité n’est plus à prouver. L’objectif de ces travaux est d’élucider le mystère qui entoure son mécanisme d’action et de découvrir ses cibles. Les dernières études redéfinissent le paracétamol comme un précurseur métabolique à l’origine d’un dérivé lipidique actif, nommé AM404. Ce dernier serait synthétisé dans certaines régions cérébrales exprimant l’enzyme FAAH capable de catalyser cette réaction. Le mécanisme alors mis en jeu montre que le paracétamol, via l’AM404, activerait les récepteurs TRPV1 centraux et indirectement les récepteurs CB1 pour renforcer un mécanisme central d’atténuation de la douleur via les voies descendantes sérotoninergiques. Cependant, le noyau cérébral concerné et le mécanisme cellulaire mis en jeu demeurent inconnus. Des données comportementales associées à une étude d’imagerie fonctionnelle ont levé le voile sur plusieurs régions cérébrales potentiellement impliquées dans l’action du paracétamol, notamment la substance grise périaqueducale. Cette dernière a suscité notre intérêt, car ce noyau exprime à la fois la triade FAAH/TRPV1/CB1, mais aussi est un carrefour des voies descendantes sérotoninergiques. Une activation dans la substance grise périaqueducale des récepteurs TRPV1 et CB1 est à même de produire un effet antinociceptif dépendant de ces contrôles descendants. Ces travaux de thèse ont conduit à conforter que l’action antalgique du paracétamol implique un mécanisme supra-spinal dépendant de l’enzyme FAAH en condition pathologique. Plus précisément, nous avons étudié le rôle de la triade FAAH/TRPV1/CB1 au niveau de la SGPA. Nous avons découvert que le paracétamol interagissait avec une voie de signalisation cellulaire mGLUR5-PLC-DAGL responsable de la production de l’endocannabinoïde 2-AG. Ce mécanisme pourrait à la fois expliquer l’étroite collaboration existant entre les récepteurs TRPV1 et CB1 dans l’effet antalgique du paracétamol et le renforcement des voies descendantes sérotoninergiques. Le paracétamol est donc un promédicament dont l’action cérébrale recruterait un ensemble de systèmes complexes pour médier son effet antalgique. Ce mécanisme séduisant ouvre la piste à de nouveaux antalgiques toujours plus efficaces avec des effets indésirables moindres, à l’image du paracétamol.\n\n... AM404 as a novel metabolite for paracetamol was shown to activate the endocannabinoid system and to also activate the transient receptor potential vanilloid-1 (TRPV-1) channel, both of which are involved in the modulation of pain signaling and proposed to mediate the analgesic action of paracetamol [86][87][88][89][90]. Prior to the work by Högestätt et al. (2005) AM404 was shown to have analgesic properties mediated through the inhibition of endocannabinoid reuptake, thereby by preventing the reuptake of anandamide from the synaptic cleft [91]. Experiments in which the conversion of p-aminophenol into AM404 has been interrupted using FAAH knockout mice or selective FAAH inhibitors, the analgesic actions of paracetamol were shown to be blocked [89,90,92,93]. The serotonergic system has also been shown to be targeted by the paracetamol-derived AM404 [94,95]. ..."
    }
}